Skip to main content
Canadian Medical Association Journal logoLink to Canadian Medical Association Journal
letter
. 1984 Feb 15;130(4):341–343.

Drugs, heat stroke and dantrolene.

R T Paasuke
PMCID: PMC1876148  PMID: 6140999

Full text

PDF
341

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Caroff S. N. The neuroleptic malignant syndrome. J Clin Psychiatry. 1980 Mar;41(3):79–83. [PubMed] [Google Scholar]
  2. Coons D. J., Hillman F. J., Marshall R. W. Treatment of neuroleptic malignant syndrome with dantrolene sodium: a case report. Am J Psychiatry. 1982 Jul;139(7):944–945. doi: 10.1176/ajp.139.7.944. [DOI] [PubMed] [Google Scholar]
  3. Flewellen E. H., Nelson T. E., Jones W. P., Arens J. F., Wagner D. L. Dantrolene dose response in awake man: implications for management of malignant hyperthermia. Anesthesiology. 1983 Oct;59(4):275–280. doi: 10.1097/00000542-198310000-00002. [DOI] [PubMed] [Google Scholar]
  4. Lydiatt J. S., Hill G. E. Treatment of heat stroke with dantrolene. JAMA. 1981 Jul 3;246(1):41–42. doi: 10.1001/jama.1981.03320010023020. [DOI] [PubMed] [Google Scholar]
  5. Meyers E. F., Meyers R. W. Thermic stress syndrome. JAMA. 1982 Apr 16;247(15):2098–2099. [PubMed] [Google Scholar]
  6. Meyers E. F. Thermic stress syndrome. Prev Med. 1979 Jul;8(4):520–522. doi: 10.1016/0091-7435(79)90326-8. [DOI] [PubMed] [Google Scholar]
  7. Weinberg S., Twersky R. S. Neuroleptic malignant syndrome. Anesth Analg. 1983 Sep;62(9):848–850. [PubMed] [Google Scholar]

Articles from Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES